Due to steady proliferation (72 h vs. 0 h) irrespective of tumor stimulus, the CAR19‐IL24‐iNK group presented more decay of staining strength, which suggested a better survival ex vivo (Figure S4E). The gene discussed is IL24; the disease is neoplasm.